SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Coral Laboratories reports Profit after tax of Rs 25.47 Mln, in the March 2022 quarter

30 May 2022 Evaluate
Net sales declined -27.82%  to  Rs. 200.77 million from Rs. 278.16 millions.Net Profit recorded in the quarter ended March 2022 rise to 46.21% to Rs. 25.47  millions  compared to R. 17.42 millions in corresponding previous quarter.A decline of 25.82 millions was observed in the OP in the quarter ended March 2022 from 42.17 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 200.77 278.16 -27.82 756.11 965.67 -21.70 756.11 965.67 -21.70
Other Income 15.29 20.45 -25.23 48.14 37.70 27.69 48.14 37.70 27.69
PBIDT 25.82 42.17 -38.77 130.28 196.19 -33.59 130.28 196.19 -33.59
Interest 0.52 0.26 100.00 1.41 0.43 227.91 1.41 0.43 227.91
PBDT 34.89 42.10 -17.13 138.46 195.95 -29.34 138.46 195.95 -29.34
Depreciation 5.02 5.00 0.40 19.91 19.83 0.40 19.91 19.83 0.40
PBT 29.87 37.10 -19.49 118.55 176.12 -32.69 118.55 176.12 -32.69
TAX 4.40 19.68 -77.64 28.10 40.58 -30.75 28.10 40.58 -30.75
Deferred Tax 3.90 -0.32 -1318.75 0.60 -4.42 -113.57 0.60 -4.42 -113.57
PAT 25.47 17.42 46.21 90.45 135.54 -33.27 90.45 135.54 -33.27
Equity 35.73 35.73 0.00 35.73 35.73 0.00 35.73 35.73 0.00
PBIDTM(%) 12.86 15.16 -15.17 17.23 20.32 -15.19 17.23 20.32 -15.19

Coral Laboratories Share Price

500.20 3.30 (0.66%)
09-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1779.40
Dr. Reddys Lab 1268.75
Cipla 1376.75
Zydus Lifesciences 1105.75
Lupin 2263.40
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×